GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Susmed Inc (TSE:4263) » Definitions » Return-on-Tangible-Equity

Susmed (TSE:4263) Return-on-Tangible-Equity : 4.58% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Susmed Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Susmed's annualized net income for the quarter that ended in Dec. 2023 was 円219.3 Mil. Susmed's average shareholder tangible equity for the quarter that ended in Dec. 2023 was 円4,783.0 Mil. Therefore, Susmed's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was 4.58%.

The historical rank and industry rank for Susmed's Return-on-Tangible-Equity or its related term are showing as below:

TSE:4263' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -28.72   Med: -17.28   Max: 1
Current: 1

During the past 4 years, Susmed's highest Return-on-Tangible-Equity was 1.00%. The lowest was -28.72%. And the median was -17.28%.

TSE:4263's Return-on-Tangible-Equity is ranked worse than
68.1% of 536 companies
in the Healthcare Providers & Services industry
Industry Median: 10.215 vs TSE:4263: 1.00

Susmed Return-on-Tangible-Equity Historical Data

The historical data trend for Susmed's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Susmed Return-on-Tangible-Equity Chart

Susmed Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Return-on-Tangible-Equity
-27.29 -28.72 -7.26 -1.04

Susmed Quarterly Data
Jun20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.25 23.15 -11.38 -12.19 4.58

Competitive Comparison of Susmed's Return-on-Tangible-Equity

For the Health Information Services subindustry, Susmed's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Susmed's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Susmed's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Susmed's Return-on-Tangible-Equity falls into.



Susmed Return-on-Tangible-Equity Calculation

Susmed's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jun. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=-50.749/( (4850.384+4863.195 )/ 2 )
=-50.749/4856.7895
=-1.04 %

Susmed's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=219.26/( (4730.425+4835.566)/ 2 )
=219.26/4782.9955
=4.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Susmed  (TSE:4263) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Susmed Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Susmed's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Susmed (TSE:4263) Business Description

Traded in Other Exchanges
N/A
Address
3-7-2, Honcho, Nihombashihoncho, Chuo-ku, Tokyo, JPN, 103-0023
Susmed Inc is engaged in the development of medical equipment and software systems Collection and distribution of medical information.

Susmed (TSE:4263) Headlines

No Headlines